Conference Description
The Radionuclide Theranostics for the Management of Cancer GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by March 9, 2024. Please check back for updates.
Keynote Session: Exploring the Power of Radioimmunobiology Via Switching the Radionuclides, Ligands and Immunotargets
Discussion Leaders
Speakers
-
Frank Roesch (N/A, Germany)
-
Ulli Köster (Institut Laue-Langevin, France)
Clinical Trial Updates in Radionuclide Theranostics
Discussion Leaders
-
Steven Larson (Memorial Sloan Kettering Cancer Center, United States)
Speakers
-
Daniela Niepel (Novartis, Switzerland)
-
shaemus gleason (Clarity Pharmaceuticals, United States)
-
Eileen Sneeden (RayzeBio, United States)
Radio(immuno)biology: Relative Biological Effectiveness, Dose & Immune System Interaction
Discussion Leaders
Speakers
-
John Sunderland (University of Iowa, United States)
-
Julie Nonnekens (Erasmus MC, The Netherlands)
Optimization of Targeted Delivery 1: New Probes, Radiolabeling and Click-Chemistry
Discussion Leaders
-
Justin Wilson (Cornell University, United States)
Speakers
-
Vasko Kramer (Positronpharma SA, Chile)
Post-radiotherapy response biomarkers
Discussion Leaders
-
Heiko Schoder (MSKCC, United States)
Speakers
-
Veena Venkatachalam (Harvard Medical School / Brigham and Women's Hospital, United States)
-
Edward Graves (Stanford University, United States)
-
Lea Sanford (Providentia Technologies, Cornell Tech, Weill Cornell Medicine, United States)
Optimization of Targeted Delivery 2: Pre-Targeting and Pro-Drugs
Discussion Leaders
-
Nikki Thiele (Oak Ridge National Laboratory, United States)
Speakers
-
Christine Mona (University of California Los Angeles, United States)
-
Sarah Cheal (Weill Cornell Medical College, United States)
-
Jacob Houghton (Stony Brook Cancer Center, United States)
-
Matthias Herth (University of Copenhagen, Denmark)
New Approaches in Radiopharmaceutical Therapies
Discussion Leaders
-
Riham El Khouli (University of Kentucky, United States)
Speakers
-
Pete Choyke (National Cancer Institute, NIH, United States)
Radionuclide Supply and Scaling up Manufacturing
Discussion Leaders
-
Val Nassiri (N/A, United States)
Speakers
-
Cathy Cutler (Director of MIRP, Brookhaven National Laboratory, United States)
Shifting Gears: Dose “De-escalation” for Synergistic Treatment Effect and Minimized Toxicity via Combination Therapies
Discussion Leaders
Speakers
-
Claudia Robles-Planells (Nationwide Children's Hospital, United States)
The GRC Power Hour™
Organizers
